(Total Views: 719)
Posted On: 09/17/2021 11:33:11 AM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
I am NOT a scientist, but....From Waynebluechip to me: US Patient 11,045,546 granted to Cytodyn on 7/6/2021 was and is key to winning and keeping the market after first approval. Near all human sicknesses have a relationship to Hyper inflammation in the micro environment. Cytodyn patent covers it until June 25, 2040.
Me to Waynebluechip: And that is the absolute BEST part of our long term story. Unless and until someone finds a true side effect that demonstrably reduces leronlimab's desirability in treating dozens of indications, we will eventually become THE SOC for them.
Me to Waynebluechip: And that is the absolute BEST part of our long term story. Unless and until someone finds a true side effect that demonstrably reduces leronlimab's desirability in treating dozens of indications, we will eventually become THE SOC for them.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)